Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: A canadian consensus statement
Kathleen I. Pritchard, K. A. Gelmon, D. Rayson, L. Provencher, M. Webster, D. McLeod, S. Verma
科研成果: 期刊稿件 › 文章 › 同行评审
25
引用
(Scopus)